Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Daniel Fowler, J. Hou, J. Foley, F. Hakim, J. Odom, K. Castro, C. Carter, E. Read, J. Gea-Banacloche, C. Kasten-Sportes, L. Kwak, W. Wilson, B. Levine, C. June, R. Gress, M. Bishop

Research output: Contribution to journalArticle

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)429-430
Number of pages2
JournalCytotherapy
Volume4
Issue number5
DOIs
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Cancer Research
  • Transplantation

Cite this

Fowler, D., Hou, J., Foley, J., Hakim, F., Odom, J., Castro, K., Carter, C., Read, E., Gea-Banacloche, J., Kasten-Sportes, C., Kwak, L., Wilson, W., Levine, B., June, C., Gress, R., & Bishop, M. (2002). Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant. Cytotherapy, 4(5), 429-430. https://doi.org/10.1080/146532402320776053